Ameritas Investment Partners Inc. lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 3.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 38,299 shares of the healthcare conglomerate’s stock after selling 1,528 shares during the period. Ameritas Investment Partners Inc.’s holdings in UnitedHealth Group were worth $6,280,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Retirement Systems of Alabama increased its stake in UnitedHealth Group by 2.5% in the first quarter. Retirement Systems of Alabama now owns 640,240 shares of the healthcare conglomerate’s stock worth $105,006,000 after buying an additional 15,403 shares during the last quarter. Honeywell International Inc. purchased a new stake in UnitedHealth Group during the first quarter worth $35,262,000. Baldwin Brothers Inc. MA increased its stake in UnitedHealth Group by 20.7% in the first quarter. Baldwin Brothers Inc. MA now owns 1,249 shares of the healthcare conglomerate’s stock worth $205,000 after buying an additional 214 shares during the last quarter. Harwood Advisory Group LLC increased its stake in UnitedHealth Group by 0.8% in the first quarter. Harwood Advisory Group LLC now owns 1,885 shares of the healthcare conglomerate’s stock worth $309,000 after buying an additional 15 shares during the last quarter. Finally, Mn Services Vermogensbeheer B.V. increased its stake in UnitedHealth Group by 3.9% in the first quarter. Mn Services Vermogensbeheer B.V. now owns 25,730 shares of the healthcare conglomerate’s stock worth $3,946,000 after buying an additional 970 shares during the last quarter. 86.21% of the stock is owned by institutional investors.

Shares of UnitedHealth Group Incorporated (NYSE:UNH) traded up 0.69% during midday trading on Tuesday, reaching $193.35. The company had a trading volume of 430,205 shares. The firm’s 50 day moving average price is $190.68 and its 200-day moving average price is $176.29. The stock has a market capitalization of $186.94 billion, a price-to-earnings ratio of 23.23 and a beta of 0.64. UnitedHealth Group Incorporated has a 1-year low of $132.39 and a 1-year high of $196.04.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The firm had revenue of $50.05 billion for the quarter, compared to the consensus estimate of $49.97 billion. During the same period in the previous year, the business earned $1.96 EPS. The firm’s revenue for the quarter was up 7.7% on a year-over-year basis. Equities research analysts expect that UnitedHealth Group Incorporated will post $9.87 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 19th. Investors of record on Friday, September 8th will be paid a dividend of $0.75 per share. The ex-dividend date of this dividend is Thursday, September 7th. This represents a $3.00 annualized dividend and a yield of 1.56%. UnitedHealth Group’s dividend payout ratio (DPR) is 35.13%.

ILLEGAL ACTIVITY NOTICE: “UnitedHealth Group Incorporated (UNH) Stake Decreased by Ameritas Investment Partners Inc.” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this report on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The original version of this report can be accessed at https://www.thecerbatgem.com/2017/08/22/unitedhealth-group-incorporated-unh-stake-decreased-by-ameritas-investment-partners-inc.html.

A number of analysts recently weighed in on UNH shares. Vetr upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $179.00 target price for the company in a research report on Monday, May 15th. Jefferies Group LLC restated a “buy” rating and issued a $192.00 target price on shares of UnitedHealth Group in a research report on Friday, May 19th. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $193.00 target price for the company in a research report on Monday, May 22nd. BidaskClub upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Friday, June 9th. Finally, Stifel Nicolaus restated a “buy” rating and issued a $185.00 target price on shares of UnitedHealth Group in a research report on Wednesday, June 28th. One investment analyst has rated the stock with a hold rating and twenty-four have issued a buy rating to the stock. UnitedHealth Group has a consensus rating of “Buy” and an average price target of $203.41.

In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,540 shares of the business’s stock in a transaction dated Friday, June 2nd. The stock was sold at an average price of $178.74, for a total transaction of $990,219.60. Following the sale, the director now owns 60,516 shares in the company, valued at approximately $10,816,629.84. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total value of $969,900.00. Following the sale, the director now owns 76,058 shares in the company, valued at approximately $14,753,730.84. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 15,540 shares of company stock worth $2,873,320. 0.89% of the stock is owned by company insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Stock Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related stocks with our FREE daily email newsletter.